New York, NY -- (SBWIRE) -- 02/12/2019 -- Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens. The U.S. FDA is moving towards adopting European guidelines requiring that bovine materials be removed from culturing media for any therapeutic product containing cultured cells, thus making HPL an attractive alternative to the production and manufacturing processes. The global human platelet lysate market is segmented by product type, application, end user and geography.

To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/16789

Market Value and Forecast

PMR estimates that the global market for human platelet lysate is expected to surpass US$ 61.0 Mn by 2026 end, expanding at an impressive CAGR of 3.6% over 2018–2026. The clinical use segment clearly dominated the global human platelet lysate market, with over 93.5% value share in 2017. The segment is expected to grow at 3.7% CAGR over the forecast period of 2018 – 2026. Matured markets of North America and Europe collectively accounted for 67.5% value share in the global human platelet lysate market in 2017. Emerging economies of Asia Pacific are expected to contribute significantly in the global human platelet lysate market during the forecast period.

human-platelet-lysate-market.jpg

Market Dynamics

Academic & research institutes segment holds maximum share as maximum number of research and development activities are performed in academic & research institutes. The increasing popularity of human platelet lysate amongst professionals is expected to be the key growth driver of the human platelet lysate market. Human platelet lysate is a convenient alternative to fetal bovine serum (FBS) as an in-vitro cell culture growth supplement and will be a great benefit in near future for various therapeutic applications. Over the past few years, the market for human platelet lysate has seen tremendous growth due to large donated blood pool in most of the developed countries, which has increased the demand for human platelet lysate. However, potential entrants in this market need to spend a lot of time and resources to understand the needs and specifications of the scientists/researchers and the research process with specific indication to tailor the product and competitive pricing constraints, which are the major factors limiting the growth of global market.

Key Regions

The global market for human platelet lysate is segmented in to five key regions viz. North America, Latin America, Europe, Asia Pacific (APAC) and the Middle East and Africa (MEA). With nearly 37.7% market share, North America dominated the global human platelet lysate market in 2017, partly due to increasing research and development activities, particularly stem cell and biopharmaceutical across the U.S. Emerging economies of Asia Pacific are expected to contribute significantly in the global human platelet lysate market during the forecast period. The rising demand for animal-free serum media is also expected to flourish the growth of the human platelet lysate market during the forecast period

Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/16789

Key Players

Some of the key players identified in the global human platelet lysate market are Merck KGaA, Compass Biomedical Inc., Macopharma SA, Cook Medical (Cook Regentec), Mill Creek Life Sciences Llc., Stemcell Technologies Inc., Zen-Bio, Inc., Sclavo Diagnostics International Srl, Life Science Group Limited, and Trinova Biochem Gmbh, among others. The domestic players are quiet aggressive and also competing with the international players. These companies are looking for opportunities to strengthen their distribution channel in other geographies.